NVUS - Novus Therapeutics Inc. (NVUS) CEO Dr. David-Alexandre Gros on Novus Therapeutics Acquisition of Anelixis Therapeutics (Transcript)
Novus Therapeutics, Inc. (NVUS)
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
September 15, 2020 08:30 AM ET
Company Participants
Jon Kuwahara - SVP, Finance & Administration
Keith Katkin - Chairman of the Board of Directors of Novus Therapeutics
Dr. David-Alexandre Gros - CEO
Steve Perrin - President and Chief Scientific Officer
Conference Call Participants
Presentation
Operator
Good morning and welcome to Novus Therapeutics Conference Call. At this time, all participant lines are in a listen-only mode. Please be advised that the call is being recorded.
Now, I'd like to turn the call over to Jon